Melanoma Moon Shot Annual Report 2013

submitted by: mdanderson
The University of Texas MD Anderson Cancer Center in September 2012 launched its Moon Shots Program, an ambitious and comprehensive action plan to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths. Initial moon shot cancers are breast and ovarian; acute myeloid leukemia and myelodysplastic syndromes; chronic lymphocytic leukemia; lung; melanoma and prostate cancer. Jeffrey Gershenwald, M.D., professor in MD Anderson's...

Prostate Cancer Moon Shot Annual Report 2013

submitted by: mdanderson
The University of Texas MD Anderson Cancer Center in September 2012 launched its Moon Shots Program, an ambitious and comprehensive action plan to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths. Initial moon shot cancers are breast and ovarian; acute myeloid leukemia and myelodysplastic syndromes; chronic lymphocytic leukemia; lung; melanoma and prostate cancer. Christopher Logothetis, M.D., chair and professor,...

De geschiedenis van de Pathologie, een reis door de archieven

submitted by: LUMC_PA_MD
Technologische vooruitgang in de pathologie. Een reis door de archieven. Van anatomisch theater naar “gepersonaliseerde geneeskunde”. Deze video presentatie is gemaakt ten behoeve van de promotie van Ronald van Eijk d.d. 8 mei 2013 op het proefschrift: Technological Advances in Molecular Pathology. A journey into the Archives De presentatie geeft een populair wetenschappelijk beeld van de ontwikkelingen in de Pathologie. In de loop der eeuwen zijn er vele revolutionaire, breed...

Newly Diagnosed Symptomatic Multiple Myeloma: (mSMART) Consensus Guidelines 2013

submitted by: WentzMR

Dr. Joseph Mikhael, a Hematologist from Mayo Clinic in Arizona shares results of a consensus guideline appearing in the April 2013 issue of Mayo Clinic Proceedings, which provides a rational, safe, and effective update to the changing field of multiple myeloma treatment. Available at: http://tinyurl.com/c7s3jbv

Geomapping reveals environmental influence on behaviors and cancer risk

submitted by: mdanderson

In her research, Lorraine Reitzel, Ph.D., uses geographic information systems technology, with the help of Seann Regan, to obtain information about a geographic area. This allows her to better understand why people engage in certain behaviors and how their environment impacts health and cancer risk.

Metabolic Syndrome as a Risk Factor for Barrett’s Esophagus

submitted by: WentzMR

Noting a 2-fold increase in risk of Barrett’s Esophagus, Dr. Cadman Leggett, a fellow in gastroenterology at Mayo Clinic in Rochester, MN, discusses his article appearing in the February 2013 issue of Mayo Clinic Proceedings which establishes an association between metabolic syndrome and esophageal cancer. Available at: http://tinyurl.com/arjjan7

Incidence of MGUS and Estimation of Duration Before Recognition

submitted by: WentzMR
Dr. Terry Therneau, a Professor of Biostatistics at Mayo Clinic in Rochester, MN, discusses his article appearing online first and in the November 2012 issue of Mayo Clinic Proceedings, placing the surprising outcome among the statistics discovered in the study into perspective. Available at: http://www.mayoclinicproceedings.org/article/ S0025-6196(12)00634-9/fulltext

Incidence of MGUS & Estimation of Duration Before First Clinical Recognition

submitted by: WentzMR

Dr. Robert Kyle, professor of medicine, laboratory medicine and pathology, at Mayo Clinic in Rochester, MN, discusses his article appearing online first and in the November 2012 issue of Mayo Clinic Proceedings, where he defines MGUS and explains its role in the development of multiple myeloma and other blood disorders.
Available at: http://www.mayoclinicproceedings.org/article/S0025-6196(12)00634-9/fulltext

The High Cost of Cancer Drugs and What We Can do About it.

submitted by: WentzMR
Dr. S. Vincent Rajkumar, a Hematologist from Mayo Clinic in Rochester, MN, discusses his article appearing in the October 2012 issue of Mayo Clinic Proceedings, where he explains the reasons behind the high cost of cancer treatments in the US and provides several considerations for reducing these expenses. Available at: http://www.mayoclinicproceedings.org/article/S0025-6196(12)00738-0/fulltext Visit the Mayo Clinic Proceedings website: www.MayoClinicProceedings.org Find more videos:...

The High Cost of Cancer Drugs and What We Can do About it.

submitted by: WentzMR
Dr. Mustaqeem Siddiqui, a Hospitalist in Hematology and Oncology at Mayo Clinic in Rochester, MN, introduces his article appearing in the October 2012 issue of Mayo Clinic Proceedings on the high cost of cancer treatments. Available at: http://www.mayoclinicproceedings.org/article/ S0025-6196(12)00738-0/fulltext Visit the Mayo Clinic Proceedings website: www.MayoClinicProceedings.org Find more videos: www.YouTube.com/MayoProceedings Follow us on Twitter:...